Back
Corvus Pharmaceuticals Vs. Perspective Therapeutics Industry Stock Comparison
Buy
56
CRVS
Corvus Pharmaceuticals
Last Price:
8.18
Seasonality Move:
-6.15%
Sell
30
CATX
Perspective Therapeutics
Last Price:
7.88
Seasonality Move:
40.67%
Buy
56
Corvus Pharmaceuticals (CRVS)
is a Buy
Is Corvus Pharmaceuticals a Buy, Sell or Hold?
- The current Corvus Pharmaceuticals [CRVS] share price is $8.19. The Score for CRVS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- CRVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $7.88. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRVS Stock Price Chart
What is Corvus Pharmaceuticals's stock price today?
-
The Corvus Pharmaceuticals share price today is $8.19
The current trend is moderately bearish and CRVS is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $7.88
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
CRVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 51.74 | Buy |
| Chaikin Money Flow: | 289590 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.39 - 9.15) | Sell |
| Bollinger Bands (100): | (2.53 - 7.19) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.91 | Sell |
| Relative Strength Index (14 RSI): | 19.21 | Sell |
| Chaikin Money Flow: | -1814221 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.47 - 12.81) | Sell |
| Bollinger Bands (100): | (11.15 - 14.37) | Sell |
CRVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.86 | Sell |
| 20-day SMA: | 8.61 | Sell |
| 50-day SMA: | 6.77 | Buy |
| 200-day SMA: | 3.41 | Buy |
| 8-day EMA: | 8.71 | Sell |
| 20-day EMA: | 8.37 | Sell |
| 50-day EMA: | 7.03 | Buy |
| 200-day EMA: | 4.18 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.48 | Sell |
| 20-day SMA: | 11.39 | Sell |
| 50-day SMA: | 12.61 | Sell |
| 200-day SMA: | 12.8 | Sell |
| 8-day EMA: | 10.03 | Sell |
| 20-day EMA: | 11.13 | Sell |
| 50-day EMA: | 12.15 | Sell |
| 200-day EMA: | 11.67 | Sell |
Corvus Pharmaceuticals Earnings Growth & CRVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.42 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.33 per share.
Corvus Pharmaceuticals Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||